Lyumjev

insulin lispro · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Lyumjev, covering 2020-06-15 to 2026-07-13. Get the full timeline:

Most recent: EMA Authorised: Lyumjev (previously Liumjev) (insulin lispro) — Eli Lilly Nederland B.V.